Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Prophylactic Antibiotics Duration

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06885450Completed

Perforator Pedicled V-Y Advanced Flaps for Coverage in the Lower Limbs

NCT05389605Completed

Outcomes of Local Perforator Flaps in Oncoplastic Surgery

NCT05088239Completed

Deep Inferior Epigastric Artery Flap for Breast Reconstruction

Showing all 3 trials

Research Network

Common Treatments

  • Prophylactic Antibiotics Duration1
  • No Intervention Was Undertaken1
  • Perforator Pedicled Flaps1

Active Sponsors

  • Aga Khan University1
  • Chiayi Christian Hospital1
  • The Affiliated Hospital of Xuzhou Medical University1

Top Investigators

Related Conditions

  • Breast Cancer2
  • Antiinfectives Adverse Reaction1
  • Infections1
  • Breast Tumor1
  • Breastq1

Activity Timeline